IDWeek: Clesrovimab reduces RSV disease, hospitalization in healthy infants
There were no treatment or RSV-related deaths during the study.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
What to expect during the 2024-2025 flu season
Trivalent seasonal influenza vaccines include 2 influenza A viruses (H1N1) and 1 influenza B virus.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
Phase 2/3 trial of new omicron-targeted vaccine shows efficacy in adolescents
A single dose of the mRNA-1273.222 vaccine demonstrated strong immune responses against various omicron subvariants and showed a favorable safety profile compared to existing vaccines.
Antibiotics treatment duration for community-acquired pneumonia
Rana Hamdy, MD, discussed her session at the 2024 AAP meeting, highlighting treatment duration with antibiotics for community-acquired pneumonia as well as the importance of understanding amoxicillin allergy.